← Back to catalogue
Vascular Endothelial Growth Factor Chemiluminescence Immunoassay Kit
EUDAMEDClass IVD General (EU MDR)
Ref S2068E-200Ref S2068E-100Ref S2068E-25Ref S2068E-50
Identity
- Device Name
- Vascular Endothelial Growth Factor Chemiluminescence Immunoassay Kit EUDAMED
- Model / Reference
- S2068E-200 EUDAMEDS2068E-100 EUDAMEDS2068E-25 EUDAMEDS2068E-50 EUDAMED
Identifiers
- Primary DI / UDI-DI
- 06955792714755 EUDAMED06955792714731 EUDAMED06955792714700 EUDAMED06955792714717 EUDAMED
- Basic UDI-DI
- B-06955792714755 EUDAMEDB-06955792714731 EUDAMEDB-06955792714700 EUDAMEDB-06955792714717 EUDAMED
- EMDN Code
- W0102060499 ENDOCRINE HORMONES (GROWTH FACTORS) - OTHER EUDAMED
Classification
- Device Class
- Class IVD General EUDAMED
- Market of Registration
- France EUDAMED
Clinical & Handling
Sterile
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
Yes
EUDAMED
Microbial Substances
Yes
EUDAMED
Reagent
Yes
EUDAMED
Self Testing
No
EUDAMED
Near-Patient Testing
No
EUDAMED
Professional Testing
Yes
EUDAMED
Companion Diagnostics
No
EUDAMED
Surgical Instrument
No
EUDAMED
Vascular Endothelial Growth Factor Chemiluminescence Immunoassay Kit by Sansure Biotech Inc. — Class IVD General — IVDD — listed in EUDAMED
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/IVDD
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/IVDD | B-06955792714755 | Class IVD General | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Sansure Biotech Inc.
- EUDAMED SRN
- CN-MF-000011392
- Authorised Representative
- Obelis s.a. BE-AR-000000106
Sources (4)
- EUDAMED d36dc49d-c1be-43eb-8516-57eec35d804e 61 fields · synced Aug 3, 2026
- EUDAMED 3cd6ffc9-c196-46cd-9ce5-922ea4f81112 61 fields · synced May 17, 2026
- EUDAMED 83ea26df-7e67-49ab-b43c-7a3951c7de8f 61 fields · synced May 17, 2026
- EUDAMED 72cab18a-ad85-4e37-b9db-d7ba435f5102 61 fields · synced May 19, 2026